Abstract

The efficacy of quantitative ultrasound (QUS) multi-parametric imaging in conjunction with unsupervised classification algorithms was investigated for the first time in characterizing intra-tumor regions to predict breast tumor response to chemotherapy before the start of treatment. QUS multi-parametric images of breast tumors were generated using the ultrasound radiofrequency data acquired from 181 patients diagnosed with locally advanced breast cancer and planned for neo-adjuvant chemotherapy followed by surgery. A hidden Markov random field (HMRF) expectation maximization (EM) algorithm was applied to identify distinct intra-tumor regions on QUS multi-parametric images. Several features were extracted from the segmented intra-tumor regions and tumor margin on different parametric images. A multi-step feature selection procedure was applied to construct a QUS biomarker consisting of four features for response prediction. Evaluation results on an independent test set indicated that the developed biomarker coupled with a decision tree model with adaptive boosting (AdaBoost) as the classifier could predict the treatment response of patient at pre-treatment with an accuracy of 85.4% and an area under the receiver operating characteristic (ROC) curve (AUC) of 0.89. In comparison, the biomarkers consisted of the features derived from the entire tumor core (without consideration of the intra-tumor regions), and the entire tumor core and the tumor margin could predict the treatment response of patients with an accuracy of 74.5% and 76.4%, and an AUC of 0.79 and 0.76, respectively. Standard clinical features could predict the therapy response with an accuracy of 69.1% and an AUC of 0.6. Long-term survival analyses indicated that the patients predicted by the developed model as responders had a significantly better survival compared to the non-responders. Similar findings were observed for the two response cohorts identified at post-treatment based on standard clinical and pathological criteria. The results obtained in this study demonstrated the potential of QUS multi-parametric imaging integrated with unsupervised learning methods in identifying distinct intra-tumor regions in breast cancer to characterize its responsiveness to chemotherapy prior to the start of treatment.

Highlights

  • The efficacy of quantitative ultrasound (QUS) multi-parametric imaging in conjunction with unsupervised classification algorithms was investigated for the first time in characterizing intratumor regions to predict breast tumor response to chemotherapy before the start of treatment

  • A novel method was investigated to predict breast cancer response to neoadjuvant chemotherapy (NAC) using the characteristics of distinct intra-tumor regions on QUS multi-parametric images acquired at pre-treatment

  • A modified HMRFEM algorithm was applied to segment the intra-tumor regions on QUS parametric images acquired from locally advanced breast cancer (LABC) patients

Read more

Summary

Introduction

The efficacy of quantitative ultrasound (QUS) multi-parametric imaging in conjunction with unsupervised classification algorithms was investigated for the first time in characterizing intratumor regions to predict breast tumor response to chemotherapy before the start of treatment. The results obtained in this study demonstrated the potential of QUS multi-parametric imaging integrated with unsupervised learning methods in identifying distinct intra-tumor regions in breast cancer to characterize its responsiveness to chemotherapy prior to the start of treatment. For monitoring and evaluating breast cancer response to NAC, functional imaging techniques including positron emission tomography (PET) and magnetic resonance imaging (MRI) have been investigated and shown promise within weeks after the treatment ­initiation[19,20,21]. These modalities are often expensive with long scan times and need injection of contrast agents to detect functional changes in tumor in response to treatment. Efficacy of the QUS parameters derived from the analysis of normalized power spectrum of RF signal, including mid-band fit (MBF), spectral slope (SS), spectral 0-MHz intercept (SI), effective scatterer diameter (ESD) and effective acoustic concentration (EAC) have been demonstrated in detecting and characterizing different abnormalities including prostate and breast cancer, intraocular tumors and cardiovascular ­disease[23,24,25,26,27,28]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call